Correlation Between Molecular Genetic Analysis and Nuclear Pleomorphism in Long-Term Recurrent and Metastatic Chordoma
Authors:
- Sarah Rebecca UllmannSUSarah Rebecca Ullmann
- Julian SchreierJSJulian Schreier
- Juan Carlos Alberto Uribe CaputiJCJuan Carlos Alberto Uribe Caputi
- Marilena GeorgiadesMGMarilena Georgiades
- Joana Maria UllmannJUJoana Maria Ullmann
- Christoph H. LohmannCLChristoph H. Lohmann
- Martin RöpkeMRMartin Röpke
- Denny SchanzeDSDenny Schanze
- Sabine FrankeSFSabine Franke
- Franziska Sabrina KarrasFKFranziska Sabrina Karras
- Albert RoessnerARAlbert Roessner
Open Access
Abstract
Background/Objectives: Recurrences and metastases occur frequently in chordoma and are the main factors influencing overall survival. However, prognostic biomarkers for recurrence remain limited. This study examines whether quantitative nuclear morphometry can capture recurrence evolution and whether it aligns with immunophenotype and genomic profiling. Methods: A total of 26 specimens from 12 adults (8 patients with non-recurrent tumors and 4 patients with multiple long-term recurrences and metastases over 7 to 16 years) were analyzed using whole-exome sequencing, immunohistochemistry, and nuclear morphometry. Results: Imaging studies and routine histology showed no consistent differences between groups. Morphometry revealed substantial intertumoral variability among non-recurrent tumors and significant longitudinal nuclear remodeling throughout recurrences, dominated by increased nuclear size and asymmetry, as well as altered shape. Primary tumors from patients who later recurred had smaller, more asymmetric, and denser nuclei than non-recurrent tumors. Recurrent samples showed higher proliferation and decreased lamin A/C expression, with focal disruption and detachment from the nuclear envelope in pleomorphic nuclei. The tumor mutational burden was low overall, varied between patients and timepoints, and tended to be higher in recurrent cases. Conclusions: Quantitative nuclear morphometry, integrated with immunophenotyping and genomic profiling, captures recurrence-associated phenotypic remodeling in chordoma and may provide a quantitative framework for future digital pathology or AI approaches, pending validation in larger cohorts.Keywords
All Related Versions
This publication has 93 references indexed in Scilit:
- At the nucleus of cancer: how the nuclear envelope controls tumor progressionMedcomm, 2025
- Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomasCancer Immunology, Immunotherapy, 2022
- Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancerJournal of Gastroenterology, 2021
- Chordome: Gibt es eine molekulargenetische Grundlage für Diagnostik und Therapie?Der Pathologe, 2020
- Tumor mutation burden and recurrent tumors in hereditary lung cancerCancer Medicine, 2019
- Expression of Lamin A/C in early-stage breast cancer and its prognostic valueBreast Cancer Research and Treatment, 2019
- Loss of SMARCB1/INI1 expression in poorly differentiated chordomasActa Neuropathologica, 2010
- Cancer nucleus: Morphology and beyondDiagnostic Cytopathology, 2010
- Sacral Chordoma: Can Local Recurrence After Sacrectomy Be Predicted?Clinical Orthopaedics and Related Research, 2008
- Skull base and nonskull base chordomasCancer, 2003